Repligen Corp. (RGEN)

161.54 -5.77 (-3.45%) USD  |  NASDAQ  |  Jan 14, 13:54
More

Repligen Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Enovis Corp. Upgrade
Perspective Therapeutics, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade
VolitionRX Ltd. Upgrade